Cerora

Cerora is a private U.S. neurodiagnostics and digital health company developing multimodal biosensor tools for objective brain health assessment. Its lead product platform, Borealis, combines electroencephalography, cognitive testing, voice and other biosensor data to support clinicians evaluating concussion and traumatic brain injury, with broader ambitions in cognitive impairment and Alzheimer's disease. The company positions its technology as a portable, point-of-care adjunct to standard clinical assessment rather than a therapeutic product. Cerora appears to remain an operating private company with an active website and management team pages, but there is limited evidence of broad commercial deployment or late-stage regulatory progress. Overall, it is best characterized as an early-stage medical device and healthcare IT company focused on brain assessment and neurodiagnostic decision support.